Delivery Order SPE2DB25D3201-SPE2DB25FNVWF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packages) under a firm fixed price contract. The award, issued on September 15, 2025, with an ultimate completion date of October 6, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of October 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28 units) on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,015.80 on May 2, 2025, for the supply of Tasigna 150 mg capsules (28-count packaging). This firm fixed-price, non-set-aside contract is scheduled for completion by May 23, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed-price contract valued at $12,015.80, with completion scheduled by September 9, 2025. This is a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count units) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVWFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units). This firm fixed-price, non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, and vaccines. All of AmerisourceBergen's reviewed contract awards with DLA have been competitively awarded without set-asides, demonstrating the company's capability to meet federal procurement requirements through open competition. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 8/22/25 |